
    
      OBJECTIVES:

        -  Investigate the effectiveness of flecainide in the management of neuropathic pain.

      OUTLINE: Patients are given a brief pain inventory (BPI) form to assess their pain upon
      enrollment in the study. Following a 7 day stabilization period, flecainide is administered.
      One capsule of flecainide is given twice a day on days 8-10, two capsules are given twice a
      day on days 11-14 and three capsules are given twice a day on days 15-21. BPI forms are
      completed on days 8, 15 and 22 to assess neuropathic pain.

      PROJECTED ACCRUAL: A total of 7-20 patients will be accrued for this study.
    
  